Martingale Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
|
|||||
|
2025
Q1 | $1.11M | Buy |
|
|||||
|
2024
Q4 | $976K | Buy |
|
|||||
|
2024
Q3 | $1.21M | Buy |
|
|||||
|
2024
Q2 | $847K | Hold |
|
|||||
|
2024
Q1 | $895K | Hold |
|
|||||
|
2023
Q4 | $796K | Buy |
|
|||||
|
2023
Q3 | $788K | Buy |
|
|||||
|
2023
Q2 | $639K | Buy |
|
|||||
|
2023
Q1 | $475K | Buy |
|
|||||
|
2022
Q4 | $646K | Buy |
|
|||||
|
2022
Q3 | $554K | Buy |
|
|||||
|
2022
Q2 | $387K | Buy |
|
|||||
|
2022
Q1 | $369K | Buy |
|
|||||
|
2021
Q4 | $420K | Sell |
|
|||||
|
2021
Q3 | $409K | Buy |
|
|||||
|
2021
Q2 | $208K | Hold |
|
|||||
|
2021
Q1 | $275K | Sell |
|
|||||
|
2020
Q4 | $265K | Sell |
|
|||||
|
2020
Q3 | $974K | Sell |
|
|||||
|
2020
Q2 | $2.23M | Buy |
|